Based in Melbourne, Australia, Brandon Capital Partners is a fund management business focused on investments in life science ventures.
Brandon Capital Partners is a funds management business aiming to generate quality returns for Australia's leading superannuation funds by investing in innovative life science ventures. Our team works with entrepreneurs to build businesses, creating value for the entrepreneurs, their teams and our investors.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 6, 2022
Entact Bio
|
Series A | $81M | Biopharma | — |
Nov 22, 2022
CatalYm
|
Series C | €50M | Biotechnology | Yes |
May 18, 2022
OncoRes Medical
|
Series A | $9.50M | Biotechnology | Yes |
Sep 15, 2021
Allay Therapeutics
|
Series C | $60M | Biotechnology | — |
Jan 1, 2019
Allay Therapeutics
|
Series B | $25M | Biotechnology | — |